In situ Raman spectroscopy for in-line control of pharmaceutical crystallization and solids elaboration processes: A review

Chemical Engineering Research and Design

Volumn 85, Issue 7 A, 2007, Pages 906-920

  Fevotte G ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE SPIN   (France)

Author keywords

Control; Crystallization; Particulate processes; Polymorphism; Process analytical technology (PAT)

Indexed keywords

CRYSTALLIZATION; DRUG PRODUCTS; POLYMORPHISM; RAMAN SPECTROSCOPY; SOLIDS;

CRYSTALLIZATION PROCESSES; IN SITU RAMAN SPECTROSCOPY; PHARMACEUTICAL CRYSTALLIZATION; SOLIDS ELABORATION;

PROCESS CONTROL;

CRYSTALLIZATION; DRUG PRODUCTS; POLYMORPHISM; PROCESS CONTROL; RAMAN SPECTROSCOPY; SOLIDS;

EID: 34547773743     PISSN: 02638762     EISSN: None     Source Type: Journal    
DOI: 10.1205/cherd06229     Document Type: Review

References (93)

1. Agarwal, P. and Berglund, K.A., 2003, In situ monitoring of calcium carbonate polymorphs during batch crystallization in the presence of polymeric additives using Raman spectroscopy, Crystal Growth & Design, 3(6): 941-946.
2. Airaksinen, S., Luukkonen, P., Jørgensen, A., Karjalainen, M., Rantanen, J. and Yliruusi, J., 2003, Effects of excipients on hydrate formation in wet masses containing theophylline, J Pharm Sci, 92(3): 516-528.
3. Aoun-Habbache, M., Guillemet-Fritsch, S., Lemaitre, J. and Jones, A., 2005, Investigation of nucleation and crystal growth kinetics of nickel manganese oxalates, Journal of Crystal Growth, 279(3-4): 531-539.
4. Auer, M.E., Griesser, U.J. and Sawatzki, J., 2003, Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy, Journal of Molecular Structure, 661-662: 307-317.
5. Barett, P. and Glennon, B., 2002, Characterizing the metastable zone width and solubility curve using Lasentec FBRM and PVM, Chem Eng Res Dev, 80(A7): 799-805.
6. Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W. and Morris, J., 2001, Ritonavir: An extraordinary example of conformational polymorphism, Pharmaceutical Research, 18(6): 859-866.
7. Bernstein, J. and Henck, J.O., 1998, Disappearing and reappearing polymorphs - An anathema to crystal engineering? Crystal Engineering, 1(2): 119-128.
8. Blanco, M., Baño, R.G. and Bertran, E., 2002, Monitoring power blending in pharmaceutical processes by use of infrared spectroscopy, Talanta, 56: 203-212.
9. Braatz, R.D., 2002, Advanced control of crystallization processes, Annual Reviews in Control, 26(1): 87-99.
10. Braatz, R.D. and Hasebe, S., 2002, Particle size and shape control in crystallization processes, AIChE Symposium Series, 326(Chemical Process Control-VI): 307-327.
11. Caillet, A., 2006, Etude de la transition de phase en solution d'un hydrate grâce à un suivis in situ par spectroscopie Raman et acquisistion d'images. Modélisation par bilans de populations, PhD dissertation, Université de Lyon, Université Lyon 1 (in French), no82-2006.
12. Caillet, A., Puel, F. and Fevotte, G., 2006, In-line monitoring of partial and overall solid concentration during solvent-mediated phase transition using Raman spectroscopy, International Journal of Pharmaceutics, 307(2): 201-208.
13. Caillet, A., Rivoire, A., Galvan, J.M., Puel, F. and Févotte, G., 2007, Crystallization of monohydrate citric acid. Part 1: in situ monitoring through the joint use of Raman spectroscopy and image analysis, Crystal Growth and Design, (accepted for publication).
14. Chen, L., Yu, Z.W. and Quinn, P.J., 2001, Kinetic phase behavior of distearoylphosphatidylethanolamine dispersed in glycerol, Biophysical Chemistry, 89(2-3): 231-238.
15. Chung, S.H.M.D.L. and Braatz, R.D., 1999, Optimal seeding in batch crystallization, Can J Chem Eng, 77: 590-596.
16. De Beer, T.R.M., Baeyens, W.R.G., Ouyang, J., Vervaet, C. and Remon, J.P., 2006, Raman spectroscopy as a process analytical technology tool for the understanding and the quantitative in-line monitoring of the homogenization process of a pharmaceutical suspension, The Analyst, 131(10): 1137-1144.
17. De Beer, T.R.M., Vergote, G.J., Baeyens, W.R.G., Remon, J.P., Vervaet, C. and Verpoort, F., 2004, Development and validation of a direct, non-destructive quantitative method for medroxyprogesterone acetate in a pharmaceutical suspension using FT-Raman spectroscopy, European Journal of Pharmaceutical Sciences, 23(4-5): 355-362.
18. de Matas, M., Edwards, H.G.M., Lawson, E.E., Shields, L. and York, P., 1998, FT-Raman spectroscopic investigation of a pseudopolymorphic transition in caffeine hydrate, Journal of Molecular Structure, 440(1-3): 97-104.
19. Desikan, S., Parsons, R.L., Davis, W.P., Ward, J.E., Marshall, W.J. and Toma, P.H., 2005, Process development challenges to accommodate a late-appearing stable polymorph: a case study on the polymorphism and crystallization of a fast-track drug development compound, Org Process Res Dev, 9(6): 933-942.
20. Doki, N., Seki, H., Takano, K., Asatani, H., Yokota, M. and Kubota, N., 2004, Process control of seeded batch cooling crystallization of the metastable a-form glycine using an in-situ ATR-FTIR spectrometer and an in-situ FBRM particle counter, Cryst Growth Des, 4(5): 949-953.
21. Falcon, J.A. and Berglund, K.A., 2004, In situ monitoring of antisolvent addition crystallization with principal components analysis of Raman spectra, Crystal Growth & Design, 4(3): 457-463.
22. Fevotte, G., 2002, New perspectives for the on-line monitoring of pharmaceutical crystallization processes using in situ infrared spectroscopy, International Journal of Pharmaceutics, 241(2): 263-278.
23. Foubert, I., Dewettinck, K. and Vanrolleghem, P.A., 2003, Modelling of the crystallization kinetics of fats, Trends in Food Science & Technology, 14(3): 79-92.
24. Fujiwara, M., Nagy, Z.K., Chew, J.W. and Braatz, R.D., 2005, First-principles and direct design approaches for the control of pharmaceutical crystallization, Journal of Process Control, 15(5): 493-504.
25. Georgieva, P., Meireles, M.J. and Feyo de Azevedo, S., 2003, Knowledge-based hybrid modelling of a batch crystallisation when accounting for nucleation, growth and agglomeration phenomena, Chem Eng Sci, 58(16): 3699-3713.
26. Grant, D.J.W., 1999, Theory and origin of polymorphism, in Brittain, H.G. (ed.). Polymorphism in pharmaceutical solids, (Marcel Dekker, New York, USA).
27. Groen, H. and Roberts, K.J., 2001, Nucleation, growth, and pseudo-polymorphic behavior of citric acid as monitored in situ by attenuated total reflection fourier transform infrared spectroscopy, Journal of Physical Chemistry B, 105(43): 10723-10730.
28. Hausman, D.S., Cambron, R.T. and Sakr, A., 2005, Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability, International Journal of Pharmaceutics, 299(1-2): 19-33.
29. Heffels, S.K. and de Jong, E.J., 1991, Improved operation and control of batch crystallisers, AIChE Symp Ser, 87(284, Part Des Cryst): 170-181.
30. Hu, Q., Rohani, S. and Jutan, A., 2005a, Modelling and optimization of seeded batch crystallizers, Computers & Chemical Engineering, 29(4): 911-918.
31. Hu, Q., Rohani, S., Wang, D.X. and Jutan, A., 2005b, Optimal control of a batch cooling seeded crystallizer, Powder Technology. Particle Technology Forum, Special Issue, 156(2-3): 170-176.
32. Hu, Y.R., Liang, J.K., Myerson, A.S. and Taylor, L.S., 2005c, Crystallization monitoring by Raman spectroscopy: Simultaneous measurement of desupersaturation profile and polymorphic form in flufenamic acid systems, Ind Eng Chem Res, 44(5): 1233-1240.
33. Johansson, J., Pettersson, S. and Taylor, L.S., 2002, Infrared imaging of laser-induced heating during Raman spectroscopy of pharmaceutical solids, Journal of Pharmaceutical and Biomedical Analysis, 30(4): 1223-1231.
34. Jones, A.G., 1974, Optimal operation of a batch cooling crystallizer, Chem Eng Sci, 29: 1075-1087.
35. Jorgensen, A., Rantanen, J., Karjalainen, M., Khriachtchev, L., Rasanen, E. and Yliruusi, J., 2002, Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis, Pharmaceutical research, 19(9): 1285-1291.
36. Jørgensen, A.C., Miroshnyk, I., Karjalainen, M., Jouppila, K., Siiriä, S., Antikainen, O. and Rantanen, J., 2006, Multivariate data analysis as a fast tool in evaluation of solid state phenomena, Journal of Pharmaceutical Sciences, 95(4): 906-916.
37. Kazarian, S.G. and Martirosyan, G.G., 2002, Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR-IR and Raman study of impregnation of ibuprofen into PVP, International Journal of Pharmaceutics, 232(1-2): 81-90.
38. Kobayashi, R., Fujimaki, Y., Ukita, T. and Hiyama, Y., 2006, Monitoring of solvent-mediated polymorphic transitions using in situ analysis tools, Org Process Res Dev, 10(6): 1219-1226.
39. Kramer, H.J.M. and Jansens, P.J., 2003, Tools for design and control of industrial crystallizers - state of art and future needs Chemical Engineering & Technology, 26(3): 247-255.
40. Larsen, P.A., Rawlings, J.B. and Ferrier, N.J., 2006, An algorithm for analyzing noisy, in situ images of high-aspect-ratio crystals to monitor particle size distribution, Chem Eng Sci, 61(16): 5236-5248.
41. Lehto, V.P., Tenho, M., Vaha-Heikkila, K., Harjunen, P., Paallysaho, M., Valisaari, J., Niemela, P. and Jarvinen, K., 2006, The comparison of seven different methods to quantify the amorphous content of spray dried lactose, Powder Technol, 167(2): 85-93.
42. Lewiner, F., Klein, J.P., Puel, F. and Fevotte, G., 2001, On-line ATR FTIR measurement of supersaturation during solution crystallization processes. Calibration and applications on three solute/solvent systems, Chemi Eng Sci, 56(6): 2069-2084.
43. Lewiner, F., Fevotte, G. and Klein, J.P., 2002, An online strategy to increase the average crystal size during organic batch cooling crystallization, Ind Eng Chem Res, 41(5): 1321-1328.
44. Ma, D.L. and Braatz, R.D., 2003, Robust identification and control of batch processes, Computers & Chemical Engineering, 2nd Pan American Workshop in Process Systems Engineering, 27(8-9): 1175-1184.
45. Ma, D.L., Tafti, D.K. and Braatz, R.D., 2002a, Optimal control and simulation of multidimensional crystallization processes, Computers & Chemical Engineering, 26(7-8): 1103-1116.
46. Ma, D.L., Tafti, D.K. and Braatz, R.D., 2002b, High-resolution simulation of multidimensional crystal growth, Ind Eng Chem Res, 41: 6217-6223.
47. Matthews, H.B., Miller, S.M. and Rawlings, J.B., 1996, Model identification for crystallization: Theory and experimental verification, Powder Technology, First International Particle Technology Forum, 88(3): 227-235.
48. Monnier, O., Fevotte, G., Hoff, C. and Klein, J.P., 1997, Model identification of batch cooling crystallizations through calorimetry and image analysis, Chem Eng Sci, 52(7): 1125-1139.
49. Muller, M., Meier, U., Wieckhusen, D., Beek, R., Pfeffer-Hennig, S. and Schneeberger, R., 2006, Process development strategy to ascertain reproducible API polymorph manufacture, Crystal Growth & Design, 6(4): 946-954.
50. Mullin, J.W. and Nyvlt, J., 1971, Programmed cooling of batch crystallizers, Chem Eng Sci, 26: 369-377.
51. Nakamura, T., Sadakane, Y. and Fujii, N., 2006, Kinetic study of racemization of aspartyl residues in recombinant human [alpha]A-crystallin, Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics, 1764(4): 800-806.
52. Nemet, Z., Hegedus, B., Szantay, Jr, C., Sztatisz, J. and Pokol, G., 2005, Pressurization effects on the polymorphic forms of famotidine, Thermochimica Acta, 430(1-2): 35-41.
53. O'Brien, L.E., Timmins, P., Williams, A.C. and York, P., 2004, Use of in situ FT-Raman spectroscopy to study the kinetics of the ftransformation of carbamazepine polymorphs, Journal of Pharmaceutical and Biomedical Analysis, 36(2): 335-340.
54. Okumura, T. and Matsuoka, M., 2005, Evaluation of the microcrystallinity of a drug substance, Indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy, Pharm Res, 22(8): 1350-1357.
55. Ono, T., ter Horst, J.H. and Jansens, P.J., 2004a, Quantitative measurement of the polymorphic transformation of L-glutamic acid using in-situ Raman spectroscopy, Crystal Growth & Design, 4(3): 465-469.
56. Ono, T., Kramer, H.J.M., ter Horst, J.H. and Jansens, P.J., 2004b, Process modeling of the polymorphic transformation of L-Glutamic acid, Cryst Growth Des, 4(6): 1161-1167.
57. O'Sullivan, B., Barrett, P., Hsiao, G., Carr, A. and Glennon, B., 2003, In situ monitoring of polymorphic transitions, Organic Process Research & Development, 7(6): 977-982.
58. Oullion, M., Puel, F., Righini, S., Carvin, P. and Févotte, G., 2007, Industrial batch crystallization of a plate-like organic product. In situ monitoring and 2D-CSD modelling. Part 2: Kinetic modelling and identification, Chem. Eng. Sci, in press, accepted manuscript, available online 29 September 2006.
59. Patience, D.B., Dell'Orco, P.C. and Rawlings, J.B., 2004, Optimal operation of a seeded pharmaceutical crystallization with growth-dependent dispersion, Org Process Res Dev, 8(4): 609-615.
60. Patience, D.B. and Rawlings, J.B., 2001, Particle-shape monitoring and control in crystallization processes, AIChE J., 47(9): 2125-2130.
61. Pratiwi, D., Fawcett, J.P., Gordon, K.C. and Rades, T., 2002, Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectrscopy and principal component analysis, European Journal of Pharmaceutics and Biopharmaceutics, 54: 337-341.
62. Puel, F., Fevotte, G. and Klein, J.P., 2003a, Simulation and analysis of industrial crystallization processes through multidimensional population balance equations, Part 1: a resolution algorithm based on the method of classes, Chem Eng Sci, 58(16): 3715-3727.
63. Puel, F., Fevotte, G. and Klein, J.P., 2003b, Simulation and analysis of industrial crystallization processes through multidimensional population balance equations. Part 2: a study of semi-batch crystallization, Chem Eng Sci, 58(16): 3729-3740.
64. Qu, H., Louhi-Kultanen, M., Rantanen, J. and Kallas, J., 2006, Solvent-mediated phase transformation kinetics of an anhydrate/hydrate system, Crystal Growth & Design, 6(9): 2053-2060.
65. Ramkrishna, D., 2000, Population Balances (Academic Press, London, UK).
66. Randolph, A.D. and Larson, M.A., 1988, Theory of Particulate Processes, 2nd ed. (Academic Press, New York, USA).
67. Rawlings, J.B., Sink, C.W. and Miller, S.M., 2002, Control of crystallization processes in Handbook of Industrial Crystallization, 2nd edition: 201-230 Myerson, A.S. (Ed) (Butterworth-Heinemann, Boston, USA).
68. Rawlings, J.B., Witkowski, W.R. and Eaton, J.W., 1992, Modelling and control of crystallizers, Powder Technol, 69(1): 3-9.
69. Rodriguez-Hornedo, N., Nehm, S.J., Seefeldt, K.F., Pagan-Torres, Y. and Falkiewicz, C.J., 2006, Reaction crystallization of pharmaceutical molecular complexes, Mol Pharm, 3(3): 362-367.
70. Salameh, A.K. and Taylor, L.S., 2006, Physical stability of crystal hydrates and their anhydrates in the presence of excipients, Journal of Pharmaceutical Sciences, 95(2): 446-461.
71. Sarkar, D., Rohani, S. and Jutan, A., 2006, Multi-objective optimization of seeded batch crystallization processes, Chem Eng Sci, 61(16): 5282-5295.
72. Schöll, J., Bonalumi, D., Vicum, L., Mazzotti, M. and Muller, M., (2006a), In situ monitoring and modeling of the solvent-mediated polymorphic transformation of L-glutamic acid, Crystal Growth & Design, 6(4): 881-891.
73. Schöll, J., Vicum, L., Müller, M. and Mazzotti, M., 2006b, Precipitation of L-glutamic acid: determination of nucleation kinetics, Chem Eng Technol, 29(2): 257-264.
74. Schwartz, A.M. and Berglund, K.A., 1999, The use of Raman spectroscopy for in situ monitoring of lysozyme concentration during crystallization in a hanging drop, Journal of Crystal Growth, 203(4): 599-603.
75. Schwartz, A.M. and Berglund, K.A., 2000, In situ monitoring and control of lysozyme concentration during crystallization in a hanging drop, Journal of Crystal Growth, 210(4): 753-760.
76. Schwartz, A.M. and Berglund, K.A., 2001, Comparison of supersaturation profiles employed on lysozyme crystallization from a hanging drop, Crystal Growth & Design, 1(1): 81-85.
77. Starbuck, C., Spartalis, A., Wai, L., Wang, J., Fernandez, P., Lindemann, C.M., Zhou, G.X. and Ge, Z., 2002, Process optimization of complex pharmaceutical polymorphic system via in situ Raman spectroscopy, Crystal Growth & Design, 2(6): 515-522.
78. Tamagawa, R.E., Miranda, E.A. and Berglund, K.A., 2002a, Simultaneous monitoring of protein and (NH4)2SO4 concentrations in aprotinin hanging-drop crystallization using Raman spectroscopy, Crystal Growth & Design, 2(6): 511-514.
79. Tamagawa, R.E., Miranda, E.A. and Berglund, K.A., 2002b, Raman spectroscopic monitoring and control of aprotinin supersaturation in hanging-drop crystallization, Crystal Growth & Design, 2(4): 263-267.
80. Threlfall, T.L., 1995, Analysis of organic polymorphs. A review, Analyst (Cambridge, United Kingdom), 120(10): 2435-2460.
81. Ulrich, J., 2003, Solution crystallization - developoments and new trends, Chem Eng Technol, 26(8): 832-835.
82. Vankeirsbilck, T., Vercauteren, A., Baeyens, W. and Van der Weken, G., 2002, Applications of Raman spectroscopy in pharmaceutical analysis, Trends in Analytical Chemistry, 21(12): 869-877.
83. Vergote, G.J., De Beer, T.R.M., Vervaet, C., Remon, J.P., Baeyens, W.R.G., Diericx, N. and Verpoort, F., 2004, In-line monitoring of a pharmaceutical blending process using FT-Raman spectroscopy, European Journal of Pharmaceutical Sciences, 21(4): 479-485.
84. Vergote, G.J., Vervaet, C., Remon, J.P., Haemers, T. and Verpoort, F., 2002, Near-infrared FT-Raman spectroscopy as a rapid analytical tool for the determination of diltiazem hydrochloride in tablets, European Journal of Pharmaceutical Sciences, 16: 63-67.
85. Wang, F., Wachter, J.A., Antosz, F.J. and Berglund, K.A., 2000, An investigation of solvent-mediated polymorphic transformation of progesterone using in situ Raman spectroscopy, Org Proc Res Dev, 4: 391-395.
86. Warterig, S. and Neubert, R.H.H., 2005, Pharmaceutical applications of Mid-IR and Raman spectroscopy, Advanced Drug Delivery Reviews, (57): 1144-1170.
87. Wikström, H., Marsac, P.J. and Taylor, L.S., 2005, In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy, Journal of Pharmaceutical Sciences, 94(1): 209-219.
88. Williams, A.C., Cooper, V.B., Thomas, L., Griffith, L.J., Petts, C.R. and Booth, S.W., 2004, Evaluation of drug physical form during granulation, tabletting and storage, International Journal of Pharmaceutics, 275(1-2): 29-39.
89. Worlitschek, J., 2003, Monitoring, modelling and optimization of batch cooling crystallization, Zurich, Swiss Federal Institute of Technology (ETH), PhD dissertation, no5189.
90. Worlitschek, J. and Mazzotti, M., 2004, Model-based optimization of particle size distribution in batch-cooling crystallization of paracetamol, Crystal Growth & Design, 4(5): 891-903.
91. Yu, L.X, Lionberger, R.A., Raw, A.S., D'Costa, R., Wu, H. and Hussain, A.S., 2004, Applications of process analytical technology to crystallization processes, Advanced Drug Delivery Reviews, 56(3): 349-369.
92. Zhang, G.G.Z., Gu, C., Zell, M.T, Burkhardt, R.T., Munson, E.J. and Grant, D.J.W., 2002, Crystallization and transitions of sulfamerazine polymorphs, Journal of Pharmaceutical Sciences, 91(4): 1089-1100.
93. Zipp, G.L. and Randolph, A.D., 1987, Selective fines destruction in batch crystallization. 10th International Symposium on Industrial Crystallization '87; Bechyne, Czechoslovakia, ed. Nyvlt, J. and Zacek, S.